
CAS 941688-05-7
:3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
Description:
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile is a complex organic compound characterized by its unique structural features, which include a pyrrolo[2,3-d]pyrimidine moiety, a pyrazole ring, and a cyclopentyl group. This compound is typically classified as a small molecule and may exhibit biological activity, making it of interest in medicinal chemistry and drug development. The presence of the nitrile functional group suggests potential reactivity and interactions with biological targets. Its molecular structure indicates a degree of rigidity due to the cyclic components, which can influence its pharmacokinetic properties, such as solubility and permeability. Additionally, the compound's specific stereochemistry and substituent arrangements can significantly affect its biological activity and binding affinity to target proteins. Overall, this compound represents a class of heterocyclic compounds that may have applications in therapeutic areas, particularly in the development of novel pharmaceuticals.
Formula:C17H18N6
Synonyms:- 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
- Ruxolitinib Impurity 10
- rac-Ruxolitinib-d9 (major) Q: What is the storage condition of
- Ruxotinib Racemate
- rac-Ruxolitinib-d9 (major)Q: What is
- Ruxolitinib Racemate
- rac-Ruxolitinib-d9 (major)
- 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
- Ruxolitinib Impurity 7
- rac-Ruxolitinib-d9 (major) Q: What is the CAS Number of
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 4 products.
rac-Ruxolitinib
CAS:Controlled Product<p>Applications rac-Ruxolitinib is the racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.<br>References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);<br></p>Formula:C17H18N6Color and Shape:NeatMolecular weight:306.36


